Cargando…
P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428976/ http://dx.doi.org/10.1097/01.HS9.0000968896.85830.01 |
| _version_ | 1785090600234647552 |
|---|---|
| author | Jentzsch, Madlen Bischof, Lara Ussmann, Jule Brauer, Dominic Backhaus, Donata Pham Thanh, Tung Franke, Georg-Nikolaus Vucinic, Vladan Platzbecker, Uwe Schwind, Sebastian |
| author_facet | Jentzsch, Madlen Bischof, Lara Ussmann, Jule Brauer, Dominic Backhaus, Donata Pham Thanh, Tung Franke, Georg-Nikolaus Vucinic, Vladan Platzbecker, Uwe Schwind, Sebastian |
| author_sort | Jentzsch, Madlen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289762023-08-17 P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION Jentzsch, Madlen Bischof, Lara Ussmann, Jule Brauer, Dominic Backhaus, Donata Pham Thanh, Tung Franke, Georg-Nikolaus Vucinic, Vladan Platzbecker, Uwe Schwind, Sebastian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428976/ http://dx.doi.org/10.1097/01.HS9.0000968896.85830.01 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Jentzsch, Madlen Bischof, Lara Ussmann, Jule Brauer, Dominic Backhaus, Donata Pham Thanh, Tung Franke, Georg-Nikolaus Vucinic, Vladan Platzbecker, Uwe Schwind, Sebastian P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION |
| title | P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION |
| title_full | P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION |
| title_fullStr | P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION |
| title_full_unstemmed | P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION |
| title_short | P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION |
| title_sort | p497: clinical outcomes of npm1-mutated acute myeloid leukemia (aml) patients with measurable residual disease (mrd) relapse after achievement of a first mrd-negative remission |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428976/ http://dx.doi.org/10.1097/01.HS9.0000968896.85830.01 |
| work_keys_str_mv | AT jentzschmadlen p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT bischoflara p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT ussmannjule p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT brauerdominic p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT backhausdonata p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT phamthanhtung p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT frankegeorgnikolaus p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT vucinicvladan p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT platzbeckeruwe p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission AT schwindsebastian p497clinicaloutcomesofnpm1mutatedacutemyeloidleukemiaamlpatientswithmeasurableresidualdiseasemrdrelapseafterachievementofafirstmrdnegativeremission |